Woodline Partners LP Theseus Pharmaceuticals, Inc. Transaction History

Woodline Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$5.21 - $14.05 $469,014 - $1.26 Million	-90,022 Reduced 38.47%	143,980 $1.28 Million
Q4 2022 Feb 14, 2023	SELL	$4.69 - $8.36 $11,199 - $19,963	-2,388 Reduced 1.01%	234,002 $1.17 Million
Q3 2022 Nov 14, 2022	BUY	$5.7 - $8.68 $140,824 - $214,448	24,706 Added 11.67%	236,390 $1.37 Million
Q2 2022 Aug 15, 2022	SELL	$5.04 - $14.05 $193,112 - $538,339	-38,316 Reduced 15.33%	211,684 $1.17 Million
Q4 2021 Feb 14, 2022	BUY	$8.98 - $20.09 $2.25 Million - $5.02 Million	250,000 New	250,000 $3.17 Million

1.03M

Ticker THRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,713,400
Description
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.